# US 2024/0002933 A1 · Sequencing nanoparticles and methods of making the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002933 A1
- Document ID: US20240002933A1
- Status: Published application
- Kind: A1
- Application number: 18/343,696
- Filed: 2023-06-28
- Published: 2024-01-04
- Earliest claimed: 2022-06-30
- Assignees: Illumina Cambridge Limited
- Applicants: Illumina Cambridge Limited
- Inventors: Amani El Fagui; Wayne N. George
- Web page: https://patentgrep.com/patent/US20240002933A1

## CPC

- C08J 3/075: Macromolecular gels
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- C08J 3/126: {Polymer particles coated by polymer, e.g. core shell structures}
- C12Q 1/6869: Methods for sequencing
- B01L 2200/0652: Sorting or classification of particles or molecules
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/0654: Lenses; Optical fibres
- C08J 2367/04: Polyesters derived from hydroxy carboxylic acids, e.g. lactones (C08J2367/06 takes precedence)
- C08J 2433/26: Homopolymers or copolymers of acrylamide or methacrylamide
- C12Q 2563/155: Particles of a defined size, e.g. nanoparticles
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

An example of a sequencing nanoparticle includes a core of a negatively chargeable, hydrophobic polymer. Alternating layers of a positively charged acrylamide hydrogel and the negatively charged polymer are positioned on the core, wherein the positively charged acrylamide hydrogel forms an outer layer of the sequencing nanoparticle. A negatively charged primer set is attached to the outer layer.

## Claims

### Claim 1

A method, comprising:
generating a negatively charged nanoparticle with a negatively chargeable, hydrophobic polymer;
in a layer-by-layer fashion, sequentially forming layers of a positively charged acrylamide hydrogel and of the negatively chargeable, hydrophobic polymer on the negatively charged nanoparticle to form a coated nanoparticle until i) a particle size of a dry form of the coated nanoparticle ranges from about 200 nm to about 1 μm, and ii) the positively charged acrylamide hydrogel forms an outer layer of the coated nanoparticle; and
grafting a negatively charged primer set to the outer layer.

### Claim 2 (depends on 1)

The method as defined in claim 1, wherein the negatively chargeable, hydrophobic polymer is selected from the group consisting of poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), poly(ε-caprolactone) (PCL), and poly(glycolic acid) (PGA).

### Claim 3 (depends on 1)

The method as defined in claim 1, wherein generating the nanoparticle of the negatively chargeable, hydrophobic polymer involves flash nanoprecipitation.

### Claim 4 (depends on 1)

The method as defined in claim 1, wherein the positively charged acrylamide hydrogel includes quaternary ammonium cations.

### Claim 5

A method, comprising:
grafting a negatively charged primer set to an acrylamide hydrogel, thereby generating a negatively charged pre-grafted acrylamide hydrogel;
generating a nanoparticle having a core and a positively charged polymer coating at a surface of the core; and
attaching the negatively charged pre-grafted acrylamide hydrogel to the positively charged polymer coating.

### Claim 6 (depends on 5)

The method as defined in claim 5, wherein generating the nanoparticle involves a modified flash nanoprecipitation process utilizing polyethyleneimine, chitosan, poly(L-lysine), or poly(diallyldimethylammonium chloride) poly(allylamine hydrochloride) (PAH) as a non-solvent phase during precipitation of the core.

### Claim 7 (depends on 5)

The method as defined in claim 5, wherein the core includes a negatively chargeable, hydrophobic polymer selected from the group consisting of poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), poly(ε-caprolactone) (PCL), and poly(glycolic acid) (PGA).

### Claim 8

A sequencing nanoparticle, comprising:
a core of a negatively chargeable, hydrophobic polymer;
alternating layers of a positively charged acrylamide hydrogel and the negatively chargeable, hydrophobic polymer positioned on the core, wherein the positively charged acrylamide hydrogel forms an outer layer; and
a negatively charged primer set attached to the outer layer.

### Claim 9 (depends on 8)

The sequencing nanoparticle as defined in claim 8, wherein:
the negatively chargeable, hydrophobic polymer is selected from the group consisting of poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), poly(ε-caprolactone) (PCL), and poly(glycolic acid) (PGA); and
the positively charged acrylamide hydrogel includes quaternary ammonium cations.

### Claim 10

A sequencing nanoparticle, comprising:
a core of a negatively chargeable, hydrophobic polymer;
a positively charged polymer coating attached to the core; and
a negatively charged pre-grafted acrylamide hydrogel attached to the positively charged polymer coating.

### Claim 11 (depends on 10)

The sequencing nanoparticle as defined in claim 10, wherein:
the negatively chargeable, hydrophobic polymer is selected from the group consisting of poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), poly(ε-caprolactone) (PCL), and poly(glycolic acid) (PGA);
the positively charged polymer coating is polyethyleneimine; and
the pre-grafted acrylamide hydrogel is poly(N-(5-azidoacetamidylpentyl)acrylamide-co-acrylamide having forward and reverse primers grafted thereto.
